← Back to headlines
Jefferies Raises Price Target on Krystal Biotech to $371
Jefferies has increased its price target for Krystal Biotech, Inc. (KRYS) to $371, while maintaining a Buy rating on the stock.
21 Feb, 11:32 — 21 Feb, 11:32
Sources
Showing 1 of 1 sources
